229 related articles for article (PubMed ID: 9828024)
1. United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange.
Bandarenko N; Brecher ME
J Clin Apher; 1998; 13(3):133-41. PubMed ID: 9828024
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Altuntas F; Aydogdu I; Kabukcu S; Kocyigit I; Cikim K; Sari I; Erkut MA; Eser B; Ozturk A; Kaya E; Cetin M; Keskin A; Unal A
Transfus Apher Sci; 2007 Feb; 36(1):57-67. PubMed ID: 17240195
[TBL] [Abstract][Full Text] [Related]
4. Apheresis and the thrombotic thrombocytopenic purpura syndrome: current advances in diagnosis, pathophysiology, and management.
Brailey LL; Brecher ME; Bandarenko N
Ther Apher; 1999 Feb; 3(1):20-4. PubMed ID: 10079801
[TBL] [Abstract][Full Text] [Related]
5. Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura.
Hong H; Xiao W; Stempak LM; Sandhaus LM; Maitta RW
Transfusion; 2015 Apr; 55(4):756-65. PubMed ID: 25370931
[TBL] [Abstract][Full Text] [Related]
6. Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state.
Hay SN; Egan JA; Millward PA; Bandarenko N; Brecher ME
Ther Apher Dial; 2006 Jun; 10(3):237-41. PubMed ID: 16817787
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acquired Thrombotic Thrombocytopenic Purpura in the U.S. remains heterogeneous: Current and future points of clinical equipoise.
Mazepa MA; Raval JS; Brecher ME; Park YA
J Clin Apher; 2018 Jun; 33(3):291-296. PubMed ID: 29150875
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of lymphoplasmapheresis compared with therapeutic plasma exchange for thrombotic thrombocytopenic purpura: a retrospective evaluation.
Zhang Z; Yuan X; Jiang Y; Li N; Li B
Hematology; 2022 Dec; 27(1):167-172. PubMed ID: 35068383
[TBL] [Abstract][Full Text] [Related]
9. The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura.
O'Brien KL; Price TH; Howell C; Delaney M
J Clin Apher; 2013 Dec; 28(6):416-21. PubMed ID: 23857424
[TBL] [Abstract][Full Text] [Related]
10. How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey.
Patriquin CJ; Clark WF; Pavenski K; Arnold DM; Rock G; Foley SR;
J Clin Apher; 2017 Aug; 32(4):246-256. PubMed ID: 27476033
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic plasma exchange-free treatment for first-episode TTP: A systematic review.
Wang J; Cheng F; Niu Y; Yan L; Li J; Tan B; Qin L
Transfus Apher Sci; 2023 Jun; 62(3):103661. PubMed ID: 36878741
[TBL] [Abstract][Full Text] [Related]
12. Therapeutical plasma exchange for thrombotic thrombocytopenic purpura in the emergency department: A single center experience.
Li XM; Mo XY; Huang GQ; Zhang FJ
Am J Emerg Med; 2021 Aug; 46():556-559. PubMed ID: 33214018
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic thrombocytopenic purpura: early and late responders.
Sarode R; Gottschall JL; Aster RH; McFarland JG
Am J Hematol; 1997 Feb; 54(2):102-7. PubMed ID: 9034283
[TBL] [Abstract][Full Text] [Related]
14. Platelet recovery rate during plasma exchange predicts early and late responses in patients with thrombotic thrombocytopenic purpura.
Liu C; Kallogjeri D; Dynis M; Grossman BJ
Transfusion; 2013 May; 53(5):1096-107. PubMed ID: 22905833
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic thrombocytopenic purpura: A 5-year tertiary care centre experience.
Swart L; Schapkaitz E; Mahlangu JN
J Clin Apher; 2019 Feb; 34(1):44-50. PubMed ID: 30536422
[TBL] [Abstract][Full Text] [Related]
16. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
Coppo P; Bussel A; Charrier S; Adrie C; Galicier L; Boulanger E; Veyradier A; Leblanc T; Alberti C; Azoulay E; Le Gall JR; Schlemmer B
Medicine (Baltimore); 2003 Jan; 82(1):27-38. PubMed ID: 12544708
[TBL] [Abstract][Full Text] [Related]
17. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Bittencourt CE; Ha JP; Maitta RW
PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients.
Raval JS; Mazepa MA; Rollins-Raval MA; Kasthuri RS; Park YA
Transfusion; 2020 Aug; 60(8):1676-1680. PubMed ID: 32696551
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.
Stefanello B; De Paula EV; Andrade Orsi F; Comenalli Marques JF; Gasparotto Roveri E; Pereira Colella M; Castro Ozelo M; Maria Annichino-Bizzacchi J; Addas-Carvalho M
J Clin Apher; 2014 Dec; 29(6):311-5. PubMed ID: 24890787
[TBL] [Abstract][Full Text] [Related]
20. Influence of type of exchange fluid on survival in therapeutic apheresis for thrombotic thrombocytopenic purpura.
Owens MR; Sweeney JD; Tahhan RH; Fortkolt P
J Clin Apher; 1995; 10(4):178-82. PubMed ID: 8770709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
